Recognizing, reducing risk of bone fractures in pediatric patients with rheumatic disease, taking glucocorticoid therapy
2014 ACR/ARHP Annual Meeting: Autoimmune Connective Tissue Diseases and Cancer
Links between autoimmunity, malignancy prompt rheumatologists to include cancer screening for patients
2014 ACR/ARHP Annual Meeting: Methotrexate Use in Patients with RA
Review of clinical research on methotrexate therapy, effect on patients’ functionality, tolerability, adverse events
2014 ACR/ARHP Annual Meeting: Sjögren’s Complications
Tips to screen for, treat central or peripheral nervous system disorders, lymphoma in patients with Sjögren’s syndrome
2014 ACR/ARHP Annual Meeting: Super Proteins Eyed in Therapies for Rheumatic Diseases
Immunoglobulin superfamily of proteins, CTLA-4 and PD-1, may generate treatments for RA, SLE
2014 ACR/ARHP Annual Meeting: Rheumatologic Research Uncovers Clues to Therapies
Studies explore role of STING pathway in bone remodeling, denosumab to reduce fracture risk, autotaxin’s role in fibrosis, SSc
2014 ACR/ARHP Annual Meeting: Rheumatoid Arthritis Management Treatment Recommendations
The ACR shares highlights of in-development guidelines for RA combination strategies, live vaccines and biologics
Does Gastric Bypass Result in Reduced Absorption of Methotrexate?
Data suggest changes in physiology of the gut post-bariatric surgery may result in medication malabsorption of immunosuppressive drugs
2014 ACR/ARHP Annual Meeting: Medical Education Trends
Patient-centeredness, teaching hospitals, clinical competency most popular published topics in medical literature last year
2014 ACR/ARHP Annual Meeting: New Directions for Gout
Economics of care, more aggressive treatment targets needed for better gout management